Showing results (2431-2440 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 26, 2020
Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cellsZhaoliang Su, Ping Ni, Peng She, et al.Cancer Immunology, Immunotherapy : CII|January 26, 2020
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trialSteve Boudewijns, Martine Bloemendal, Nienke de Haas, et al.Cancer Immunology, Immunotherapy : CII|September 11, 2020
Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancerH Adderley, F H Blackhall, C R LindsayCancer Immunology, Immunotherapy : CII|September 12, 2020
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)J Chandra, W P Woo, N Finlayson, et al.Cancer Immunology, Immunotherapy : CII|September 12, 2020
Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm studyAsmaa M Zahran, Helal F Hetta, Shimaa Mansour, et al.Cancer Immunology, Immunotherapy : CII|January 27, 2019
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primatesLuca Cassetta, Espen S Baekkevold, Sven Brandau, et al.Cancer Immunology, Immunotherapy : CII|January 29, 2019
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinomaDavid Agdashian, Mei ElGindi, Changqing Xie, et al.Cancer Immunology, Immunotherapy : CII|March 1, 2018
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine modelsHeinz Läubli, Philipp Müller, Lucia D'Amico, et al.Cancer Immunology, Immunotherapy : CII|April 14, 2006
Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10Nicolas Larmonier, Marilyn Marron, Yi Zeng, et al.Cancer Immunology, Immunotherapy : CII|April 14, 2006
Targeted and shielded adenovectors for cancer therapySusan J Hedley, Jian Chen, John D Mountz, et al.Pageof 652